Standing Tall launched a roasted soybean snack line aimed at the perimenopause/menopause shopper. 12g protein per serving, non-GMO North American soybeans. Founded by a 50-year-old industry veteran who started developing it after researching her own symptoms.

Standing Tall launched roasted soybean snacks aimed squarely at women navigating perimenopause and menopause. Founder Attessa Bradley, 50, a CPG industry veteran, started developing the product after experiencing her own symptoms and researching how nutrition could help. The science is straightforward: soy is a complete plant protein delivering all nine essential amino acids, plus isoflavones (natural plant compounds that act similarly to estrogen). At 12 grams of protein per serving from non-GMO North American soybeans, boiled, dry-roasted and seasoned, the product positions more like a nut than a processed food. The brand is also explicitly going after the 30-plus-year-old myth that soy causes breast cancer, which was popularized in the 1990s based on rodent studies and which medical research has since walked back.

The interesting strategic read here is about the menopause CPG market specifically. This is the fastest-growing under-served category in food and supplements right now. Almost every brand competing here so far has been supplement-led (Womaness, Equelle, plus the wave of HRT-adjacent products). Standing Tall is one of the first to compete from inside the food and snacking aisle, which is a much larger and easier-to-scale category if the velocity works. The myth-busting angle is also smart marketing. Targeting the specific demographic that grew up with the "soy causes cancer" narrative and giving them an evidence-based reframe creates an emotional and intellectual hook that broader functional snack positioning doesn't carry.

For functional snack operators and menopause-focused CPG founders: how big is the menopause snacking opportunity right now, and how should we expect the category to segment over the next 24 months? And on the myth-busting marketing angle: when is taking on outdated category science a smart wedge vs. an expensive education burden the brand can't afford?

Source - Nosh